Search

Author/Creator Boulard, C.

1. Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus. (3rd April 2016)

Authors:
Boulard, C.; Duvert Lehembre, S.; Picard‐Dahan, C.; Kern, J.S.; Zambruno, G.; Feliciani, C.; Marinovic, B.; Vabres, P.; Borradori, L.; Prost‐Squarcioni, C.; Labeille, B.; Richard, M.A.; Ingen‐Housz‐Oro, S.; Houivet, E.; Werth, V.P.; Murrell, D.F.; Hertl, M.; Benichou, J.; Joly, P.
Other Names:
Hofmann S. investigator.; Camaioni B. investigator.; Didona B. investigator.; Fania L. investigator.; Della Torre R. investigator.; Caux F. investigator.; Alexandre M. investigator.; Paul C. investigator.; Bulai Livideanu C. investigator.; Delaporte E. investigator.; Dupuy A. investigator.; Avene...
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus. (1st July 2016)

Authors:
Boulard, C.; Duvert Lehembre, S.; Picard‐Dahan, C.; Kern, J.S.; Zambruno, G.; Feliciani, C.; Marinovic, B.; Vabres, P.; Borradori, L.; Prost‐Squarcioni, C.; Labeille, B.; Richard, M.A.; Ingen‐Housz‐Oro, S.; Houivet, E.; Werth, V.P.; Murrell, D.F.; Hertl, M.; Benichou, J.; Joly, P.; Hofmann, S.
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus4. (3rd April 2016)

Authors:
Boulard, C.; Duvert Lehembre, S.; Picard‐Dahan, C.; Kern, J.S.; Zambruno, G.; Feliciani, C.; Marinovic, B.; Vabres, P.; Borradori, L.; Prost‐Squarcioni, C.; Labeille, B.; Richard, M.A.; Ingen‐Housz‐Oro, S.; Houivet, E.; Werth, V.P.; Murrell, D.F.; Hertl, M.; Benichou, J.; Joly, P.
Other Names:
Hofmann S. investigator.; Camaioni B. investigator.; Didona B. investigator.; Fania L. investigator.; Della Torre R. investigator.; Caux F. investigator.; Alexandre M. investigator.; Paul C. investigator.; Bulai Livideanu C. investigator.; Delaporte E. investigator.; Dupuy A. investigator.; Avene...
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting. (30th July 2019)

Authors:
Fougerousse, A.‐C.; Maccari, F.; Beauchet, A.; Parier, J.; Boulard, C.; Becherel, P.‐A.; Quiles‐Tsimaratos, N.; Le Guyadec, T.; Thomas‐Beaulieu, D.; Halioua, B.; Begon, E.; Bastien, M.; Perrot, J.‐L.; Pallure, V.; Bilan, P.; Steff, M.; Pfister, P.; Vermersch‐Langlin, A.; Boyé, T.; Mery‐Bossard, L.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 33:Number 12(2019)
Page Start:
e476
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid. (1st December 2021)

Authors:
Hébert, V.; Bastos, S.; Drenovska, K.; Meijer, J.; Ingen‐Housz‐Oro, S.; Bedane, C.; Lunardon, L.; Debarbieux, S.; Jedlickova, H.; Caux, F.; Chaby, G.; D'Incan, M.; Feliciani, C.; Boulard, C.; Schumacher, N.; Schmidt, E.; Roussel, A.; Richard, M.A.; Gottlieb, J.; Ferranti, V.
Journal:
British journal of dermatology
Issue:
Volume 185:Number 6(2021)
Page Start:
1232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid. (2nd September 2021)

Authors:
Hébert, V.; Bastos, S.; Drenovska, K.; Meijer, J.; Ingen‐Housz‐Oro, S.; Bedane, C.; Lunardon, L.; Debarbieux, S.; Jedlickova, H.; Caux, F.; Chaby, G.; D'Incan, M.; Feliciani, C.; Boulard, C.; Schumacher, N.; Schmidt, E.; Roussel, A.; Richard, M.A.; Gottlieb, J.; Ferranti, V.
Journal:
British journal of dermatology
Issue:
Volume 185:Number 6(2021)
Page Start:
1232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing. (1st November 2020)

Authors:
Le Cleach, L.; Dousset, L.; Assier, H.; Fourati, S.; Barbarot, S.; Boulard, C.; Bourseau Quetier, C.; Cambon, L.; Cazanave, C; Colin, A.; Kostrzewa, E.; Lesort, C.; Levy Roy, A.; Lombart, F.; Marco‐Bonnet, J.; Monfort, J.‐B.; Samimi, M.; Tardieu, M.; Wolkenstein, P.; Sbidian, E.
Journal:
British journal of dermatology
Issue:
Volume 183:Number 5(2020)
Page Start:
866
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing. (9th August 2020)

Authors:
Le Cleach, L.; Dousset, L.; Assier, H.; Fourati, S.; Barbarot, S.; Boulard, C.; Bourseau Quetier, C.; Cambon, L.; Cazanave, C; Colin, A.; Kostrzewa, E.; Lesort, C.; Levy Roy, A.; Lombart, F.; Marco‐Bonnet, J.; Monfort, J.‐B.; Samimi, M.; Tardieu, M.; Wolkenstein, P.; Sbidian, E.
Journal:
British journal of dermatology
Issue:
Volume 183:Number 5(2020)
Page Start:
866
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology. (12th May 2021)

Authors:
Guelimi, R.; Salle, R.; Dousset, L.; Assier, H.; Fourati, S.; Bhujoo, Z.; Barbarot, S.; Boulard, C.; Cazanave, C.; Colin, A.; Kostrzewa, E.; Lesort, C.; Levy Roy, A.; Lombart, F.; Marco Bonnet, J.; Marty, L.; Monfort, J.B.; Riffaud, L.; Samimi, M.; Tardieu, M.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 35:Number 9(2021)
Page Start:
e539
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗